Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in Cancer
Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2018.00370
Full Text
Open PDFAbstract
Available in full text
Date
September 11, 2018
Authors
Publisher
Frontiers Media SA